Danda Pharma v EMA: ECFI 22 Dec 2021

(Order) Action for annulment – Medicinal products for human use – Marketing authorization for the medicinal product Hopveus – Non-renewal of a permanent scientific advisory group – Lack of interest in bringing proceedings – Inadmissibility

Citations:

T-381/21, [2021] EUECJ T-381/21_CO, ECLI:EU:T:2021:960

Links:

Bailii

Jurisdiction:

European

Licensing, Health

Updated: 04 May 2022; Ref: scu.676309